City

Houston (2)

Duarte (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (2)

City of Hope Medical Center (1)

Collaborator

National Cancer Institute (NCI) (3)

Study Documents

Intervention Type

drug (3)

biological (2)

other (1)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

pleomorphic variant mantle cell lymphoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

Not yet recruiting

Blastoid Variant Mantle Cell Lymphoma
+2 more

Biopsy
+8 more

Duarte, California

City of Hope Medical Center

May 15, 2023

Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

Recruiting

Blastoid Variant Mantle Cell Lymphoma
+8 more

Houston, Texas

M D Anderson Cancer Center

Dec 5, 2022

Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)

Active, not recruiting

Blastoid Variant Mantle Cell Lymphoma
+3 more

Cyclophosphamide
+10 more

Houston, Texas

M D Anderson Cancer Center

Mar 8, 2022